Lialda is a Oral Tablet, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Shire Us Manufacturing Inc.. The primary component is Mesalamine.
Product ID | 54092-476_0fe0314c-771b-45d5-ac5b-9879eb121aba |
NDC | 54092-476 |
Product Type | Human Prescription Drug |
Proprietary Name | Lialda |
Generic Name | Mesalamine |
Dosage Form | Tablet, Delayed Release |
Route of Administration | ORAL |
Marketing Start Date | 2007-01-16 |
Marketing Category | NDA / NDA |
Application Number | NDA022000 |
Labeler Name | Shire US Manufacturing Inc. |
Substance Name | MESALAMINE |
Active Ingredient Strength | 1 g/1 |
Pharm Classes | Aminosalicylate [EPC],Aminosalicylic Acids [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2007-01-16 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022000 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2007-01-16 |
Marketing Category | NDA |
Application Number | NDA022000 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2007-01-16 |
Marketing Category | NDA |
Application Number | NDA022000 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2007-01-16 |
Marketing Category | NDA |
Application Number | NDA022000 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2007-01-16 |
Ingredient | Strength |
---|---|
MESALAMINE | 1.2 g/1 |
SPL SET ID: | 3098a080-be86-4265-9818-7fc4beab77b7 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |